title: The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia.
abstract: The catechol-O-methyl transferase (COMT) 158Val/Met variant has been suggested to play a role in COMT function. Epigenetic regulation of COMT may further influence the prevalence of metabolic syndrome in these patient populations. This study examined the correlation between COMT promoter methylation and metabolic syndrome in schizophrenia patients receiving atypical antipsychotic (AAP) therapy. DNA was extracted from peripheral blood samples of schizophrenia subjects screened for metabolic syndrome. Pyrosequencing was used to analyze two methylation sites of the soluble COMT (COMT-s) promoter region. Associations between AAP use, lifestyle variables, metabolic syndrome and COMT genotype with peak methylation values were analyzed. Data are reported in 85 subjects. Methylation on CpG site 1 had a mean of 79.08% (±4.71) and it was 12.43% (±1.19) on site 2. COMT genotype proved to be an indicator of COMT methylation status on site 1 (F(2, 84)=5.78, P=0.0044) and site 2 (F(2, 84),=3.79, P=0.027). A significant negative correlation between physical activity and COMT promoter region methylation was found in Val/Val homozygous patients (site 1: P=0.013 and site 2: P=0.019). Those homozygous for Met/Met showed a positive correlation between promoter site methylation and physical activity (site 1: P=0.027, site 2: P=0.005), and between CpG site methylation and metabolic syndrome (site 1: P=0.002; site 2: P=0.001). The results of this study suggest that COMT promoter region methylation is largely influenced by COMT genotype and that physical activity plays a significant role in epigenetic modulation of COMT.
authors.affiliation: Department of Clinical Social and Administrative Sciences, University of Michigan College of Pharmacy, Ann Arbor, MI, USA.
authors.forename: S A
authors.initials: SA
authors.lastname: Lott
authors.forename: P R
authors.initials: PR
authors.lastname: Burghardt
authors.forename: K J
authors.initials: KJ
authors.lastname: Burghardt
authors.forename: M J
authors.initials: MJ
authors.lastname: Bly
authors.forename: T B
authors.initials: TB
authors.lastname: Grove
authors.forename: V L
authors.initials: VL
authors.lastname: Ellingrod
mesh_terms: D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D002394:Catechol O-Methyltransferase / Q000235:genetics*; D018899:CpG Islands / Q000235:genetics; D019175:DNA Methylation / Q000235:genetics; D005260:Female; D056726:Genetic Association Studies; D005838:Genotype; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000235:genetics*; D008875:Middle Aged; D009043:Motor Activity; D011401:Promoter Regions, Genetic; D012559:Schizophrenia / Q000150:complications / Q000235:genetics* / Q000473:pathology
chemical_list: D014150:Antipsychotic Agents; D002394:Catechol O-Methyltransferase